RxDoctor Payments Data

Israr Sheikh, MD

Gastroenterology · Fargo, NDNPI 1396038162

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,342 of the $5,408 with a category attached, or 61.8%. Boston Scientific accounts for 63.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $2,887 and has fallen 95.9% since, to $118 in 2025. Among gastroenterology clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,408in general payments, 2019–2025

Across 48 payments — averaging $112.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Covidien LP$1K
  • Medtronic$235
  • AbbVie$150
  • Phathom Pharmaceuticals, Inc.$116
  • Johnson & Johnson$76
  • plus $196 from 4 others

What the payments were for

  • Travel & lodging$3,34262%
  • Food & beverage$1,99037%
  • Education$761%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,408 in reported general payments places this provider in the 90th percentile of 26 gastroenterology providers in North Dakota.

See all gastroenterology providers in North Dakota

Medicare billing

Part B allowed, 2024
$199,111
Medicare patients
699
Services billed
1,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine52$11,549
LinzessLinaclotide12$10,370
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl201$4,377
Ursodiol23$3,808
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl151$3,165
Mesalamine ErMesalamine16$2,364
Balsalazide Disodium13$2,234
Budesonide DrBudesonide14$1,852
Omeprazole134$1,816
Entecavir16$704
Azathioprine19$699
Famotidine65$517
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg21$503
Pantoprazole Sodium52$499
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl12$351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$150$10,37012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 26 gastroenterology providers in North Dakota.

Other gastroenterology in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →